| Samsung Bioepis CH GmbH - Obodence, Injektionslösung in einer Fertigspritze |
| 69873 | | 01 | | Obodence | | Injektionslösung in einer Fertigspritze | | M05BX04 | | Denosumab | | 21.03.2025 | | |
|
| Composition |
| denosumabum 60 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 20, sorbitolum 44 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Denosumabum | 60 mg/ml |
| | | | Inactive agents | Dose |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Polysorbatum 20 | | | Sorbitol | 44 mg/ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | B | | No |
|
